RAEDYONT
DEAD

Serial Number

97090507

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 25, 2021

Add to watchlist:

No watchlists yet
View on USPTO

RAEDYONT Trademark

Serial Number: 97090507

RAEDYONT is a trademark filed by Novartis AG on October 25, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

October 25, 2021

Registration Date

Not Registered

Published for Opposition

February 21, 2023

Goods & Services

Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations, namely, pharmaceutical preparations for use in dermatology; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 25, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 25, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 16, 2026 EXRA
SOU EXTENSION 5 GRANTED
Mar 16, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 13, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Oct 15, 2025 EEXT
SOU EXTENSION 5 FILED
Oct 14, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 14, 2025 EXRA
SOU EXTENSION 4 GRANTED
Apr 13, 2025 EX4G
SOU EXTENSION 4 FILED
Apr 13, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 13, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 14, 2024 EXRA
SOU EXTENSION 3 GRANTED
Oct 14, 2024 EX3G
SOU EXTENSION 3 FILED
Oct 14, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2024 EXRA
SOU EXTENSION 2 GRANTED
Mar 30, 2024 EX2G
SOU EXTENSION 2 FILED
Mar 30, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 30, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 17, 2023 EXRA
SOU EXTENSION 1 GRANTED
Oct 13, 2023 EX1G
SOU EXTENSION 1 FILED
Oct 13, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 13, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 18, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 19, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 18, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 2, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 2, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 2, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 2, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2021 NWOS
NEW APPLICATION ENTERED
Oct 28, 2021 NWAP